Dr Bruno Ciancio
Dr Bruno Ciancio is a medical epidemiologist. He worked as infectious disease epidemiologist at national level in Italy and in the UK. After completing the European Programme for Intervention Epidemiology Training (EPIET), he joined the ECDC in 2006. He worked as influenza expert for five years, supporting surveillance activities, setting up a network for monitoring influenza vaccine effectiveness (I-MOVE), and developing guidelines to inform vaccination programmes. Since 2011 he is leading a team in charge of collecting, processing, analysing and presenting EU-level surveillance data. During this time, he led the re-engineering of the ECDC surveillance systems and tools to increase their efficiency and fitness for purpose. In 2018 he set up the ECDC task force on eHealth with the goal of defining a strategy for harnessing the benefits of eHealth for infectious disease surveillance and risk assessment. Dr Ciancio has authored more than forty scientific publications in peer-reviewed journals.
Shiva heads the Innovation Finance Advisory Division in the EIB. She has been at the EIB since 2003, first in Risk Management, then in its Lending Directorate financing higher risk, innovative projects before joining the Advisory Services Department.
Before EIB, Shiva was Director of High Yield at Fitch Rating Agency developing its European High Yield rating business and worked in the M&A Advisory and Emerging Markets Investment Banking Group at J.P. Morgan in New York and London.
Shiva holds a BA in Economics from Columbia University and an Executive MBA from London Business School (LBS). In 2000, Shiva co-founded the European High Yield Association (EHYA), which is now part of the Association for Financial Markets in Europe (AFME). In 2006, Credit Magazine nominated Shiva to its Top 50 Women in Credit.
Dr Frank Glod
Dr Frank Glod is the CSO of LIH, the Luxembourg Institute of Health. The institute focuses on biomedical research, while also extending its activities into clinical trials and population health.
Dr Glod holds a PhD in Chemistry from the University of Bristol and has conducted postdoctoral research at the University of Minnesota and the University of Michigan.
Before his appointment at the LIH in June 2018, Dr Glod worked at the National Research Fund (FNR), where he led several strategic initiates. These include the FNR Foresight Report, which involved coordinating the participation of international experts and stakeholders from the research community, general society and the Luxembourg financial sector in the process of identifying national research priorities. In addition, he helped implement the National Centre of Excellence's pilot programme on Parkinson's disease.
As CLINNOVA Project Coordinator, he successfully headed a Luxembourg-Danish-German consortium that obtained H2020 support (as part of the WIDESPREAD Spreading Excellence and Widening Participation call for tenders) to develop the business plan for the implementation of a Centre of Excellence (CoE) in Digital Health and Personalised Medicine.
Dr Glod has also participated in EU joint programming initiatives, as well as several ERA-NETs (ERASysBio, ERA-Net NEURON and ERA-NET NEURON II).
Christian Oberlé began his career initially as an auditor and then as a consultant.
In May 2000, he joined the management board of the fledgling Kirchberg Hospital. He oversaw the construction of the new hospital and was CFO for the merger of the Ste-Élisabeth, Sacré Cœur and St François clinics.
In 2001, he became Executive Director of the Sainte-Marie Clinic. In 2002, he presided over the acquisition of the Bohler Clinic and oversaw the construction of its new site.
Since 2006, he has simultaneously been the Executive Director of the Bohler Clinic and the CFO of Kirchberg Hospital and the Sainte-Marie Clinic.
Christian assisted with the takeover of the Zithaklinik in 2014, and in 2016 led the hospital through a major restructuring programme to merge the four institutions into one entity: Hôpitaux Robert Schuman S.A.
Since 2017, he has been Deputy Director-General of Hôpitaux Robert Schuman and Director of the Fondation Hôpitaux Robert Schuman, the sole shareholder of Hôpitaux Robert Schuman.
Alongside these duties, Christian is on the Board of Directors of the Fédération des hôpitaux
luxembourgeois and the management boards of both LUXITH and Agence eSanté.
He has been President and Director of the Caisse nationale de santé (CNS - National Health Fund), as well as President of Agence eSanté, since November 2018.
Christian studied business studies at the University of Liège’s Business Management School, and has an MBA from the Faculty of Business and Economics at the University of Lausanne.
Dr Stefan Rüping
Dr Stefan Rüping heads the Knowledge Discovery department at the Fraunhofer Institute for Intelligente Analysis and Information Systems IAIS, which is one of the leading research institutes in the area of artificial intelligence, machine learning, and big data.
He studied computer science and machine learning at the University of Dortmund, where he obtained his PhD in 2006 on the topic of learning interpretable models in machine learning. His research interests include trustworthy and transparent machine learning and the combination of data-driven and knowledge-based intelligent systems, with applications in particular in healthcare, industry 4.0, automotive and cognitive process automation. Amongst others, Stefan Rüping is part of the national German Competence Center Machine Learning Rhine-Ruhr ML2R.
Dr Andrzej Ryś
Dr Andrzej Ryś is a medical doctor specialised in radiology and public health, graduated from Jagiellonian University, Krakow, Poland. He founded in 1991 and ran as Director until 1997 the School of Public Health at the Jagiellonian University. Thereafter, from 1997 -1999, he served as Director of the Krakow’s City Health Department. Between 1999 -2002, he continued his career as Deputy Minister of Health in Poland where he was member of the Polish EU accession negotiators team for the harmonisation of the Polish Health Care Law with the EU’s Acquis Communautaire.
After becoming Senior Consultant of "Health and Management Ltd" for the World Bank (WHO) and EAR in Serbia (2002), he founded (2003) the “Center for Innovation, Technology Transfer and University Development” (CITTRU) at the Jagiellonian University, where he was Director until 2006.
In 2006, he became Director for Public Health and Risk Assessment at the Directorate-General for Health and Consumers (DG SANCO), in the European Commission. From 2011-2014, he assumed the position of Director for Health Systems and Products in DG SANCO. Since 2014, Dr Andrzej Rys is the Director responsible for Health Systems, Medical Products and Innovation in DG SANTE.